发明名称 |
Arginine antagonists for inhibition of systemic hypotension associated with nitric oxide production or endothelial derived relaxing factor |
摘要 |
A method for prophylaxis or treatment of an animal for systemic hypotension induced by internal nitrogen oxide production. The method involves administering a therapeutically effective amount of certain arginine derivatives to inhibit nitrogen oxide formation from arginine. Preferably N<G>-substituted arginine or an N<G>,N<G>-disubstituted arginine (having at least one hydrogen on a terminal guanidino amino group replaced by another atomic species) is administered to an animal possibly developing or already having such induced systemic hypotension. The arginine derivatives are preferably of the L configuration and include pharmaceutically acceptable addition salts. Prophylaxis or treatment of systemic hypotension in a patient which has been induced by chemotherapeutic treatment with biologic response modifiers such as tumor necrosis factor or interleukin-2 may be accomplished. Treatment of an animal for systemic hypotension induced by endotoxin, i.e., septic shock may also be accomplished by treatment with the arginine derivatives. |
申请公布号 |
SG48203(A1) |
申请公布日期 |
1998.04.17 |
申请号 |
SG19960007882 |
申请日期 |
1990.09.13 |
申请人 |
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM;CORNELL RESEARCH FOUNDATION INC. |
发明人 |
KILBOURNE, ROBERT, G.;GROSS, STEVEN, S.;LEVI ROBERTO;GRIFFITH, OWEN, W.;LODATO ROBERT |
分类号 |
A61K31/00;A61K31/195;A61K31/198;A61K31/223;A61K38/00;A61K38/21;A61K45/00;A61P9/02;A61P43/00;(IPC1-7):A61K31/195 |
主分类号 |
A61K31/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|